Diagnostic Approach to Neck Masses

Rationale for Fine Needle Aspiration (FNA)

The American Academy of Otolaryngology-Head and Neck Surgery recommends fine needle aspiration (FNA) as the preferred initial diagnostic procedure for evaluating suspicious neck masses in adults, providing tissue diagnosis with minimal invasiveness and high accuracy 1
FNA is the optimal first-line tissue sampling technique due to its high diagnostic accuracy with only small numbers of false-negative results 1
The American Academy of Otolaryngology-Head and Neck Surgery explicitly recommends performing FNA instead of open biopsy for patients with neck masses at increased risk for malignancy 2

A solid consistency on ultrasound indicates the need for histologic evaluation, as it is not a simple reactive node 1, 3
A painless presentation is concerning, as malignant lymphadenopathy is typically painless, unlike infectious causes 2
The mass appearing to be lymph node in consistency requires differentiation between reactive, infectious, and malignant etiologies in adults 1

Empiric antibiotics should be avoided without clear signs of bacterial infection, as this approach may delay diagnosis if malignancy is present 4
The absence of pain, fever, or recent infection makes bacterial lymphadenitis unlikely, and antibiotics are not indicated for painless masses without infectious symptoms 2

Even adequate and negative FNA results should not preclude additional diagnostic procedures in patients with worrisome signs and symptoms 1
Up to 80% of neck masses in patients over 40 years old can be malignant, particularly cystic masses 5, 6
Solid masses have 90% sensitivity for FNA diagnosis, making this an ideal candidate for FNA 3

Ultrasound-guided FNA increases specimen adequacy compared to palpation-guided aspiration 1
On-site evaluation by a cytopathologist reduces inadequacy rates and can guide immediate decision-making 1

Core biopsy is an option after inadequate or indeterminate FNA, with 95% adequacy rate and 94-96% accuracy 1
If lymphoma is suspected clinically, core needle biopsy may be considered first-line, as it has higher sensitivity than FNA for lymphoma (92% vs 74%) 1

Do not assume mobile masses are benign—mobility does not exclude early malignancy 5
Do not treat empirically with antibiotics without infectious symptoms, as this delays cancer diagnosis 4
Do not accept inadequate FNA specimens as final—distinguish between inadequate sampling versus adequate but indeterminate results 1
Do not delay workup based on patient age alone—while malignancy risk increases with age, younger adults can develop metastatic disease 5